新闻中心 - Biomatik中国区代理商/公司/官网

欢迎来到 Biomatik中国区代理商/公司/官网

全国咨询热线： 18327026838

Biomatik中国区代理商/公司/官网

产品中心

推荐产品

invivoCrown IV0120替换BioXCell BE0015-1

invivoCrown IV0102替换BioXCell BE0003-1

invivoCrown IV0104替换BioXCell BE0061

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：18372041646

传真：18327026838

邮箱：sales@amyjet.com

新闻中心

首页 > 新闻中心

艾美捷科技代理Rigaku Reagents品牌。

Rigaku Reagents 是 Rigaku 集团旗下的一家子公司，专注于为X射线晶体学领域提供高质量的化学试剂和工具。Rigaku 集团是全球知名的科学仪器制造商，尤其在X射线分析技术领域具有领先地位。Rigaku Reagents 的主要目标是支持科学家在蛋白质晶体学、材料科学和其他相关领域的研究，提供用于晶体生长、样品制备和分析的高质量试剂和耗材。热门产品包括：Wizard Classic/Wizard Cryo 系列蛋白结晶筛选试剂盒，结晶板，结晶工具，和 PEG3350、PEG6000、PEG8000 等试剂。主要产品类别为：

（1）晶体生长试剂：Rigaku Reagents 提供多种用于蛋白质和小分子晶体生长的试剂，包括结晶筛选试剂盒、缓冲液、沉淀剂和添加剂。这些试剂经过严格的质量控制，确保实验的可重复性和可靠性。

（2）结晶筛选试剂盒：公司提供多种结晶筛选试剂盒，如 Crystal Screen、Index Screen 和 SaltRx Screen，适用于不同类型的晶体生长实验。这些试剂盒设计科学，能够显著提高晶体生长的成功率。

（3）蛋白质结晶工具：提供用于蛋白质结晶的耗材和设备，如结晶板、密封膜和样品支架。这些工具与 Rigaku 的X射线衍射仪兼容，支持从晶体生长到数据分析的全流程。

（4）小分子结晶试剂：为小分子晶体学研究提供高质量的试剂和工具，支持药物开发、材料科学等领域的研究。

<<< " data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Rigaku Reagents品牌"> 艾美捷科技代理Rigaku Reagents品牌

...

阅读详情

艾美捷科技代理Stereospecific Detection Technologies品牌全系列产品

Stereospecific Detection Technologies (SDT)是一家专注于免疫分析、核酸杂交和免疫组织化学领域高性能试剂开发与生产的公司。Stereospecific Detection Technologies (SDT)生产用于ELISA、印迹(Blotting)、DNA/RNA杂交和IHC应用中超灵敏检测的试剂，Stereospecific Detection Technologies (SDT)提供三大类特种产品，以及各种免疫分析支持（辅助）试剂：多聚HRP和多聚GOD偶联物；多聚HRP稀释液、封闭剂和稳定剂；TMB 底物以及免疫分析辅助试剂。

▎Stereospecific Detection Technologies产品线

● Poly-HRP：Poly-HRP偶联物是Stereospecific Detection Technologies (SDT)独家生产的、用于超灵敏检测的独特产品。Stereospecific Detection Technologies (SDT)生产通用的：链霉亲和素-Poly-HRP、重组蛋白A-Poly-HRP、重组蛋白A/G-Poly-HRP偶联物，山羊抗小鼠IgG-Poly-HRP、兔抗小鼠IgG-Poly-HRP、山羊抗兔IgG-Poly-HRP、小鼠单克隆抗人IgG(H链, γ链特异性)-Poly-HRP和抗人 IgM (H链, µ链特异性)-Poly-HRP偶联物。

● PolyGOD：广泛应用在电化学免疫传感器、葡萄糖和氧传感、单层和多层薄膜免疫检测、过氧化物隧道免疫检测系统以及免疫组织化学(IHC)应用等领域。

● 专用辅助试剂：Stereospecific Detection Technologies (SDT)开发了用于制造高度浓缩、稳定且可通过0.2/0.45 µm滤膜过滤的酪蛋白胶体缓冲液，无生物素稀释液/封闭剂等特色产品。

● TMB底物及检测支持试剂：TMB底物包括超灵敏液态TMB（s(HS)TMB）、沉淀型膜用 TMB（p(HS)TMB）。检测支持试剂包括：浓缩的10% BSA溶液；HAMA 封闭剂；通用封闭剂；异嗜性抗体封闭剂。

▎Stereospecific Detection Technologies部分产品列表

品名	货号	规格
Streptavidin-PolyHRP20	#SP20C	0.5 mg;1 mg;10 mg;25 mg
Streptavidin-PolyHRP40	#SP40C	0.5 mg;1 mg;10 mg;25 mg
Streptavidin-PolyHRP80	#SP80C	0.5 mg;1 mg;10 mg;25 mg
Mouse monoclonal anti-human IgG (H, γ-chain specific) DY649 labeled	#MAHG-DY649	0.5 mg;1 mg
Mouse monoclonal anti-human IgG (H, γ-chain specific) PolyHRP40	#MAHGP-DY549C	0.5 mg;1 mg
Giant Premium PolyStreptAvidin	#GPPSA	1 mg;10 mg;25 mg;50 mg
Streptavidin-HRP, monomeric, cryopreserved	#SM1C	1 mg;10 mg;25 mg
High Load StrongZyme™ Streptavidin-(Poly)HRP	#HL-SZ-SA	1 mg;10 mg;25 mg
AmpliShine™ SA-PolyPE High Sensitivity Conjugate	#SAPE-AS	1 mg
SA-(mono)PE IHC Grade Conjugate	#SAPE-M	1 mg
recombinant Protein A - PolyHRP20	#AP20C	0.5 mg;1 mg;10 mg;25 mg
recombinant Protein A/G PolyHRP40	#AGP40C	0.5 mg;1 mg;10 mg
enhanced recombinant Protein A/G-PolyHRP40	#AGP40C-WB	0.5 mg;1 mg;10 mg
Goat anti-Mouse IgG (H+L)-PolyHRP40	#GAMP40C	0.5 mg;1 mg;10 mg;25 mg
Enhanced Streptavidin-PolyHRP Conjugate Stabilizer HTS-E	#SA1-HTS-E	50 ml;100 ml;250 ml;500 ml;1000 ml;10 L
Streptavidin-PolyHRP Conjugate Stabilizer RHT(Real-Time High Temperature)synthetic	#SA3-RHT	50 ml;100 ml;250 ml;500 ml;1000 ml;10 L
Antibody/Antigen (PolyHRP) Conjugate Stabilizer	#AA1	50 ml;100 ml;250 ml;500 ml;1000 ml;10 L
ep(HS)TMB-mA, enhanced stable precipitating 1-component TMB	#epTMB-mA	30 ml；60 ml;125 ml;250 ml;500 ml;1000 ml
Stop/Elution Reagent for stopping	#SER	65 ml；100 ml;250 ml;500 ml;1000 ml
Blocker of Human Anti-Mouse IgG Antibodies (HAMA)	#HAMAB	10mg；100mg
10% BSA, Ultra-pure, biotin and IgG free	#BSA1	10 ml;50 ml;100 ml;250 ml;500 ml;1000 ml
10% BSA, trace biotin and IgG	#BSA2	10 ml;50 ml;100 ml;250 ml;500 ml;1000 ml
Binding/Coating Buffer 10X Concentrate	#BBC	100 ml;250 ml;500 ml;1000 ml;1 L;10 L
Phosphate Buffered Saline (PBS) 10X Concentrate	#PBSC	100 ml;250 ml;500 ml;1000 ml;1 L;10 L
Wash Buffer 20X Concentrate	#WBC-x20	100 ml;250 ml;500 ml;1000 ml;1 L;10 L
Substrate Buffer 10X Concentrate	#SBC	100 ml;250 ml;500 ml;1000 ml;1 L;10 L
5-Bromo-5-Nitro-1,3-Dioxane	#BND-D	5 g;10 g;20 g;50 g;100 g;1000 g

" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Stereospecific Detection Technologies品牌全系列产品"> 艾美捷科技代理Stereospecific Detection Technologies品牌全系列产品

...

阅读详情

艾美捷科技代理STEMCELL Technologies品牌。

STEMCELL Technologies为世界各地从事干细胞、免疫学、癌症、再生医学和细胞治疗研究的科学家提供高质量的细胞培养基、细胞分离技术、仪器和配套产品。

STEMCELL Technologies特色产品包括：

（1）EasySep™ 总核酸提取试剂盒：磁性总核酸（DNA 和 RNA）提取试剂盒

（2）CellAdhere™ Laminin-521：与 TeSR™ 维持培养基结合用于维持人 ES 和 iPS 细胞的基质

（3）EasySep™ 人骨髓 CD138 阳性选择试剂盒 (IVD)：从骨髓中免疫磁性阳性选择人 CD138+ 细胞用于体外诊断 (IVD) 应用的样品

（4）GyneCult™ 输卵管类器官培养基：无血清和性类固醇模块化试剂盒，用于人类输卵管类器官的扩增和分化

< " data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理STEMCELL Technologies品牌"> 艾美捷科技代理STEMCELL Technologies品牌

...

阅读详情

艾美捷科技代理Rigaku Reagents品牌。

（4）小分子结晶试剂：为小分子晶体学研究提供高质量的试剂和工具，支持药物开发、材料科学等领域的研究。

<<< " data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Rigaku Reagents品牌"> 艾美捷科技代理Rigaku Reagents品牌

...

阅读详情

艾美捷科技代理Berry & Associates全系列修饰核苷酸等

美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.

Berry & Associates的主要产品包括：

产品名称	产品编号	纯度	规格
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2'-3'-Dideoxyguanosine	PR 3505	≥95%	25 mg; 100 mg
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
2',3'-Dideoxyuridine	PY 7278	≥97%	100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridine	PY 7279	≥97%	25 mg; 100 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
2-Amino-2'-deoxyadenosine	PR 3060	≥97%	1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine	PR 3080	≥95%	100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosine	PR 3130	≥95%	100 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3670	≥95%	100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine	PR 3070	≥97%	25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine	PR 3160	≥97%	100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate	PR 3180	≥97%	25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3680	≥97%	100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosine	PR 3006	≥95%	25 mg; 100 mg
8-Amino-2'-deoxyadenosine	PR 3115	≥97%	10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosine	PR 3120	≥90%	100 mg; 1 g
8-Azido-2'-deoxyadenosine	PR 3125	≥97%	10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine	PR 3230	≥95%	50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine	PR 3260	≥95%	100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosine	PR 3280	≥97%	100 mg; 1 g
8-Bromo-2'-deoxyadenosine	PR 3290	≥90%	2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3320	≥95%	100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3340	≥97%	0g (discontinued);
2'-Deoxyadenosine Monohydrate	PR 3445	≥97%	25 g; 100 g
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2-Fluoro-2'-deoxyadenosine	PR 3496	≥97%	25 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
N6-Methyl-2'-deoxyadenosine	PR 3740	≥97%	100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine	PRA 10012	≥95%	10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine	PRA 10032	≥95%	10 mg; 50 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosine	PR 3010	≥90%	0Discontinued;
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3015	≥90%	1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3020	≥90%	1 g; 10 g
5'-Azido-5'-deoxyguanosine	PR 3225	≥90%	5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3285	≥90%	1 g; 10 g
8-Bromo-2'-deoxyguanosine	PR 3300	≥90%	1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine	PR 3310	≥97%	500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3330	≥90%	250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine	PR 3335	≥95%	100 mg; 1 g
2'-Deoxyguanosine monohydrate	PR 3452	≥97%	10 g; 100 g
α-2'-Deoxyguanosine	PR 3455	≥97%	10 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine	PR 3600	≥97%	100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosine	PR 3605	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine	PR 3630	≥97%	100 mg; 1 g
N2-Ethyl-2'-deoxyguanosine	PR 3700	≥95%	25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosine	PR 3745	≥97%	10 mg; 100 mg
N1-Methyl-2'-deoxyguanosine	PR 3748	≥97%	25 mg; 1 g
N2-Methyl-2'-deoxyguanosine	PR 3750	≥97%	25 mg; 100 mg
O6-Methyl-2'-deoxyguanosine	PR 3755	≥90%	5 mg; 25 mg
6-Thio-2'-deoxyguanosine	PR 3845	≥97%	10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
2'-O-Methyladenosine	PR 3734	≥97%	1 g;
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridine	PY 7575	≥97%	10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridine	PY 7577	≥97%	10 mg; 100 mg
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine	PR 3000	≥97%	25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine	PR 3200	≥90%	50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosine	PR 3210	≥97%	10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosine	PR 3220	≥97%	10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosine	PR 3240	≥97%	100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine	PR 3250	≥97%	100 mg; 1 g
3'-Deoxyadenosine	PR 3430	≥97%	10 mg; 100 mg
3'-Deoxyguanosine	PR 3460	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine	PR 3590	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosine	PR 3690	≥97%	20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine	PY 7230	≥97%	100 mg;
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3040	≥97%	1 g;
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3045	≥95%	1 g;
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine	PR 3050	≥95%	5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3370	≥97%	100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3380	≥90%	100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine	PR 3390	≥97%	0 g;
6-Chloro-9-(β-D-ribofuranosyl)purine	PR 3400	≥97%	5 g; 10 g
Adenosine	PR 3005	≥97%	100 g; 1 kg
8-Methyladenosine	PR 3007	≥95%	25 mg; 100 mg
Vidarabine	PR 3008	≥97%	1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
N1-Methyladenosine hydroiodide	PR 3032	≥95%	100 mg; 1 g
2-Methyladenosine	PR 3035	≥97%	10 mg; 25 mg
5'-Chloro-5'-deoxyadenosine	PR 3360	≥97%	100 mg; 1 g
N6-Methyladenosine	PR 3732	≥97%	100 mg; 1 g
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10000	≥97%	100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10005	≥97%	500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine	PRA 10006	≥90%	25 mg; 100 mg
8-Azaadenosine	PRA 10007	≥97%	20 mg;
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)	PRA 10008	≥95%	10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine	PRA 10009	≥95%	100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosine	PRA 10010	≥97%	100 mg; 1 g
Allopurinol riboside	PRA 10011	≥97%	25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine	PRA 10020	≥97%	100 mg; 1 g
3-Deaza-2'-deoxyadenosine	PRA 10025	≥97%	25 mg; 100 mg
7-Deaza-2'-deoxyadenosine	PRA 10030	≥97%	100 mg; 1 g
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
7-Deaza-2'-deoxyguanosine	PRA 10040	≥97%	100 mg; 1 g
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
7-Deaza-2'-deoxyxanthosine	PRA 10050	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine	PRA 10055	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
5-Iodotubercidin	PRA 10095	≥90%	5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10100	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10110	≥97%	100 mg; 1 g
Sangivamycin	PRA 10140	≥97%	10 mg; 25 mg
Toyocamycin	PRA 10150	≥97%	10 mg; 100 mg
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
dNaM	FC 8110	≥97%	25 mg; 100 mg
9-Deaza-2'-deoxyguanosine	PRA 10120	≥97%	10 mg; 100 mg
9-Deazaguanosine	PRA 10130	≥97%	10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine	PYA 11000	≥97%	10 mg; 25 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
2'-Deoxypseudoisocytidine	PYA 11005	≥97%	10 mg; 100 mg
2'-Deoxypseudouridine	PYA 11010	Purity: ≥97%	25 mg;
5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine	PYA 11035	Purity: ≥97%	50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridine	PYA 11040	≥97%	10 mg; 100 mg
1,3-Dimethylpseudouridine	PYA 11050	≥97%	10 mg; 50 mg
N1-Methylpseudouridine	PYA 11052	≥95%	10 mg; 50 mg
N3-Methylpseudouridine	PYA 11054	≥97%	10 mg; 25 mg
Showdomycin	PYA 11056	≥97%	10 mg;
Pseudoisocytidine hydrochloride	PYA 11060	≥97%	10 mg; 100 mg
Pseudothymidine	PYA 11070	≥97%	10 mg; 100 mg
Pseudouridine	PYA 11080	≥97%	10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine	PR 3350	≥97%	10 mg;
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-Deoxy-8,5'-cycloadenosine	PR 3440	≥97%	10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosine	PR 3500	≥97%	10 mg;
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine	PR 3730	≥97%	10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosine	PR 3800	≥97%	10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosine	PR 3810	≥97%	10 mg;
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine	PY 7054	≥97%	25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
5-Bromo-2'-deoxycytidine	PY 7115	≥97%	1 g; 10 g
Cytidine	PY 7215	≥97%	50 g; 500 g
2'-Deoxycytidine	PY 7216	≥97%	10 g; 50 g
2'-Deoxycytidine Hydrochloride	PY 7217	≥97%	5 g; 50 g
5'-Azido-2',5'-dideoxycytidine	PY 7219	≥97%	25 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
N4-Ethyl-2'-deoxycytidine	PY 7245	≥97%	100 mg; 250 mg
5-Methyl-2'-deoxyisocytidine	PY 7255	≥95%	500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7270	≥97%	20 mg; 50 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7380	≥97%	50 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine	PY 7410	≥97%	100 mg;
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one	PY 7540	≥95%	250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydrate	PY 7586	≥95%	50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine	PY 7587	≥97%	10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidine	PY 7588	≥97%	50 mg; 100 mg
5-Formyl-2'-deoxycytidine	PY 7589	≥97%	5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidine	PY 7592	≥95%	25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium salt	PY 7593	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxymethylcytidine	PY 7596	≥97%	50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium salt	PY 7598	≥97%	10 mg; 50 mg
5-Formylcytidine	PY 7599	≥97%	5 mg; 10 mg
5-Iodo-2'-deoxycytidine	PY 7607	≥97%	2 g; 10 g
5-Iodocytidine	PY 7609	≥97%	5 g;
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Methyl-2'-deoxycytidine Hydrochloride	PY 7635	≥97%	0.25 g; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methylcytidine	PY 7637	≥97%	1 g; 5 g
N4-Methylcytidine	PY 7638	≥97%	25 mg; 100 mg
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
2-Thiocytidine	PY 7721	≥97%	10 mg; 100 mg
2-Thio-2'-deoxycytidine	PY 7723	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
8-Hydroxyguanosine	PR 3795	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
5-Aza-2'-deoxycytidine	PY 7105	≥95%	25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidine	PY 7106	≥97%	25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
Nap-dU	PY 7735	≥97%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
8-18O-Hydroxyguanosine	IOPR 3795	≥95%	2 mg; 5 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
N2-Dimethylguanosine	PR 3702	≥97%	10 mg; 100 mg
Guanosine	PR 3703	≥97%	100 g; 500 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
O6-Methylguanosine	PR 3757	≥97%	25 mg; 100 mg
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
8-Bromoguanosine	PR 3796	≥97%	0 g;
8-Benzyloxyguanosine	PR 3797	≥95%	100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
2'-Deoxy-4-desmethylwyosine	PR 3450	≥95%	100 mg; 500 mg
2'-Deoxyinosine	PR 3463	≥97%	10 g; 100 g
5'-Azido-2',5'-dideoxyinosine	PR 3464	≥97%	5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosine	PR 3480	≥97%	1 g;
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine	PR 3490	≥90%	1 g;
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine	PR 3660	≥97%	100 mg; 1 g
Inosine	PR 3725	≥97%	100 g; 500 g
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
O6-Phenyl-2'-deoxyinosine	PR 3840	≥97%	100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3842	≥97%	25 mg;
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3843	≥90%	25 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine	PR 3510	≥90%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3520	≥95%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3530	≥90%	100 mg; 1 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
d5SICS	FC 8120	≥97%	25 mg; 100 mg
AICA Riboside (AICAR)	MN 20001	≥97%	0 g (DISCONTINUED);
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine	PR 3692	≥95%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
tC Nucleoside	PYA 11110	≥97%	50 mg; 100 mg
tCnitro Nucleoside	PYA 11115	≥95%	5 mg; 25 mg
2'-Deoxynebularine	PR 3470	Purity: ≥97%	100 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole	PYA 11020	≥97%	50 mg;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole	PYA 11030	≥95%	100 mg;
Showdomycin	PYA 11056	≥97%	10 mg;
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pseudouridine	PYA 11080	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
Toyocamycin	PRA 10150	≥97%	10 mg;
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg;
Allopurinol riboside	PRA 10011	≥97%	25 mg;
5-Iodotubercidin	PRA 10095	≥90%	5 mg;
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg;
5'-Amino-5'-deoxythymidine	PY 7030	≥97%	25 mg; 50 mg
O2,5'-Anhydrothymidine	PY 7060	≥95%	500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
5'-Azido-5'-deoxythymidine	PY 7070	≥97%	25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7120	≥97%	1 g;
3'-O-(t-Butyldimethylsilyl)thymidine	PY 7130	≥95%	500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidine	PY 7140	≥97%	5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidine	PY 7150	≥97%	1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine	PY 7160	≥95%	100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine	PY 7200	≥95%	10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidine	PY 7210	≥95%	10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7250	≥97%	1 g;
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one	PY 7315	≥90%	1 g; 10 g
2',3'-Didehydro-3'-deoxythymidine	PY 7328	≥95%	10 mg; 100 mg
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine	PY 7510	≥97%	50 mg; 100 mg
2-O-Ethylthymidine	PY 7561	≥97%	500 mg; 1 g
5'-Iodo-5'-deoxythymidine	PY 7610	≥97%	250 mg; 1 g
5'-O-Methylthymidine	PY 7680	≥95%	50 mg; 100 mg
2-Thiothymidine	PY 7725	≥95%	20 mg; 100 mg
Thymidine	PY 7727	≥97%	25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidine	PY 7740	≥97%	5 g;
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidine	PY 7750	≥97%	50 mg;
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
6-Azathymidine	PYA 11058	≥95%	25 mg; 100 mg
NPOM-Caged-dT CEP	BA 0317	≥95%	100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
5-Ethynyl uridine CEP	BA 0353	≥90%	100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridine	PY 7053	≥97%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one	PY 7055	≥97%	20 mg; 100 mg
5-Bromo-2'-deoxyuridine	PY 7117	≥97%	10 g; 25 g
5-Bromouridine	PY 7118	≥95%	5 g;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carbomethoxyvinyl)uridine	PY 7172	≥97%	25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridine	PY 7185	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine	PY 7212	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
2'-Deoxyuridine	PY 7275	≥97%	25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine	PY 7280	≥95%	100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7310	≥97%	20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine	PY 7450	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridine	PY 7465	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-Ethynyl-2'-deoxyuridine	PY 7562	≥97%	25 mg; 100 mg
5-Ethynyl uridine	PY 7563	≥97%	10 mg; 100 mg
5-Fluoro-2'-deoxyuridine	PY 7565	≥97%	100 mg; 1 g
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7580	≥97%	25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7590	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridine	PY 7604	≥97%	25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridine	PY 7612	≥95%	100 mg;
5-Iodo-2'-deoxyuridine	PY 7615	≥97%	10 g; 25 g
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
5-Iodouridine	PY 7632	≥95%	5 g; 25 g
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
3-Methyluridine	PY 7694	≥97%	25 mg; 100 mg
5-Methyluridine	PY 7695	≥97%	200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridine	PY 7712	≥95%	10 mg; 100 mg
Zebularine	PY 7715	≥97%	10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine	PY 7720	≥90%	500 mg; 1 g
2-Thiouridine	PY 7724	≥97%	25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine	PY 7730	≥97%	1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine	PY 7758	≥97%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine	PY 7775	≥97%	100 mg; 1 g
Uridine	PY 7780	≥97%	100 g; 500 g
2'3'-O-Isopropylidene uridine	PY 7781	≥97%	5 g; 25 g
5-Hydroxymethyl uridine	PY 7782	≥97%	50 mg; 100 mg
5-Methoxyuridine	PY 7783	≥97%	10 mg; 50 mg
6-Aza-2'-deoxyuridine	PYA 11057	≥95%	50 mg; 100 mg

" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

...

阅读详情

艾美捷科技代理MicroFIT品牌全系列产品

MicroFIT是一家在生物/医疗领域具有显著影响力的企业，专注于基于模拟人体环境和组织的平台技术，致力于为生物医疗领域提供创新的产品和服务。公司以成为“基于Bio-Convergence技术的仿生平台领先企业”为目标，不断探索和研发，旨在成长为一家提供个性化医疗所需仿生平台的全球性公司。

▍MicroFIT产品线

● StemFIT 3D-Plastic系列

StemFIT 3D-Plastic系列产品采用PS（聚苯乙烯）材料设计，融合了多种实用功能，旨在使大规模3D细胞培养变得更加容易、高效和经济。能广泛应用于再生医学、精准医疗、疾病建模、发育生物学、毒物学、宿主-微生物组相互作用、药物发现和基因编辑等多个领域。

型号	H389600P-6 孔	H389600P-单人
材料	聚苯乙烯	聚苯乙烯
特征	大规模培养，经济实惠，易于移液，疏水性	大众培养，经济实惠，易于移液，疏水性
井数量	每个 2,334	389 个
井径	600 微米	600 微米
单元格数量	≥ 1.2 x 106	≥ 1.2 x 106
细胞接种培养基的体积	1 毫升	1 毫升
细胞培养基体积	3 ~ 8 毫升	3 毫升
包装	3 包/箱	20 个 EA/CS，40 个 EA/CS

● StemFIT 3D®

StemFIT 3D®是一款创新性的三维细胞培养板，带有凹形微孔的微孔板，其核心原理在于利用这些微孔将孔内的细胞浓缩，进而培养细胞聚集体。使细胞能够在三维空间内相互作用，更好地模拟了体内细胞的生长环境。StemFIT 3D®在三个维度上形成细胞聚集体，允许细胞向各个方向生长并与周围环境相互作用，通过扩散和传递为细胞提供营养、氧气和药物，从而提供更接近生物体真实情况的仿生环境。

型号	井型	井数	井径	细胞数量	播种培养基体积	总培养基体积
H1613200	Hexagon	1613	200 μm	≥ 6.0 x 105	500 μl	1 ml
H853400	Hexagon	853	400 μm	≥ 1.2 x 106	1 ml	1.5 ml
H389600L/H389600H	Hexagon	389	600 μm	≥ 1.2 x 106	1 ml	H389600L-1.3 ml；H389600H-1.7 ml
H449800	Hexagon	449	800 μm	≥ 2.4 x 106	1 ml	4 ml
H2951000	Hexagon	295	1000 μm	≥ 2.4 x 106	2 ml	4 ml
C100600	Circle	100	600 μm	≥ 6.0 x 105	2 ml	700 μl
C163000	Circle	16	3,000 μm	2.5 x 105 / well	20 μl / well	5 ml
C253000	Circle	25	3,000 μm	2.5 x 105 / well	20 μl / well	3 ml

● NanoFIT 3D®系列

NanoFIT 3D®系列细胞培养板通过实现线或柱结构的均匀纳米图案来提供仿生界面。这种独特的纳米拓扑结构能够模拟细胞外环境，允许科研人员通过诱导细胞调整其形态和排列，从而更精准地控制和分析特定细胞的反应。它有可能基于纳米图案最大限度地维持和分化细胞，在体内提供类似于ECM（细胞外基质）的环境，使细胞的形态和功能更接近体内真实状态。能维持细胞干性与分化；调节特定细胞靶向；多样化培养形式并且拥有专利技术保障。

Type	Pattern	Size	Cat. No.
Sheet (Polydimethylsiloxane)	Line	250 nm	N-Line250S
Sheet (Polydimethylsiloxane)	Line	400 nm	N-Line400S
Sheet (Polydimethylsiloxane)	Post	250 nm	N-Post250S
Sheet (Polydimethylsiloxane)	Post	400 nm	N-Post400S
Sheet (Polydimethylsiloxane)	Flat	250 nm	N-Flat250S
Sheet (Polydimethylsiloxane)	Flat	400 nm	N-Flat400S
Dish (Polystyrene)	Line	400 nm	N-Line400P

● 微珠芯片

微珠芯片是一种专为大规模生产微型珠子而设计的微流控装置。它采用先进的材料和工艺制造，旨在利用胶原蛋白、PEGDA、PLGA等多种水凝胶材料，实现高效、精准的大规模微粒生产。具有卓越的耐化学性；精密的珠子生产能力；材料坚固耐用且可重用。

● PDMS膜

PDMS膜，即聚二甲基硅氧烷膜，作为应用最为广泛的硅基有机聚合物之一，、PDMS膜具有柔软弹性，能够轻松实现大幅度的拉伸变形，且在拉伸过程中仍能保持较好的物理性能和稳定性；具备超薄膜的结构特点，厚度可以做到极薄，在保证基本功能的前提下，最大程度地减少材料的使用和空间的占用；拥有良好的透气性，它允许气体分子自由通过，在生物相容性应用中，能为细胞提供适宜的气体交换环境，促进细胞的生长和代谢；在微流体装置等应用里，也能保证气体的顺畅流通，维持系统的稳定运行；拥有优异的光学透明性，几乎不会对光线的传播产生干扰；对生物组织无毒无害，不会引发明显的免疫反应，可安全地应用于生物医学领域。

Material	Diameter	Thickness
PDMS	50 mm / 1.97 inch	10 μm
PDMS	50 mm / 1.97 inch	30 μm
PDMS	50 mm / 1.97 inch	50 μm

● PDMS定位

PDMS（聚二甲基硅氧烷）作为一种硅基弹性体，拥有高光学透明度，能让研究人员清晰地观察芯片内发生的微观反应和现象；化学稳定性极佳，可在各种化学环境下保持性能稳定；出色的变形性使其能够适应不同的实验需求和操作条件；优异的生物相容性则为生物样本的研究提供了安全可靠的环境。PDMS片上实验室采用了世界领先的PDMS LOC（Lab - on - a - Chip）技术。这项技术实现了在微米尺度上构建具有卓越成型性的纳米·微结构，将复杂的实验室功能集成到一个小小的芯片之上。

● SU-8微型模具

SU-8微型模具是一种感光聚合物模具，专门用于芯片实验室的微图案铸造。它采用环氧树脂基负光刻胶SU-8作为主要材料，通过精密的光刻工艺在晶圆上制造出微图案。相较于其他模具材料，SU-8微型模具的生产速度更快。该模具的高度可高达1,000μm，能够满足制造具有较大高度微结构的需求。这种模具在微流控芯片、生物传感器、微机电系统（MEMS）等领域的生产制造中发挥着重要作用。

通道高度	晶圆尺寸	层
100 μm 以下	4英寸	1层
100 μm 以下	6英寸	1层
110 - 200 微米	4英寸	1层
110 - 200 微米	6英寸	1层
210 - 300 微米	4英寸	2 层
310 - 500 微米	4英寸	超过 2 层
510 - 800 微米	4英寸	超过 3 层

● 晶圆厂工艺

在半导体产业飞速发展的今天，高效、精准且可靠的制造服务至关重要。MicroFIT凭借其专业的技术和丰富的经验，提供一站式的半导体制造服务，采用分布式外包流程，为客户解决各种制造难题。包括以下服务：

● 光刻：将精心设计的图案精准转移到晶圆上，这是半导体制造的关键起始步骤，为后续的工艺奠定基础，确保图案的高精度和准确性。

● 镀膜：通过各种工艺使金属、聚合物等材料以薄膜形式均匀沉积在硅衬底上，为芯片提供必要的功能层和保护层，增强芯片的性能和稳定性。

● 蚀刻：精确去除必要电路图案外的其余部分，可选择干蚀刻或湿蚀刻方法，以实现对材料的精细加工，塑造出所需的微纳结构。

● 粘接：在半导体制造中，用于将芯片与基板牢固粘合；在微流控器件制造里，用于通道形成后的处理，确保器件各部分之间的可靠连接和密封性。

● 切割：把在半导体晶片加工中制造的器件在图案形成后分离成一定的尺寸，为后续的封装和测试等步骤做准备。

● CMP（化学机械抛光）：通过化学和物理过程的结合，对晶圆或玻璃基板进行抛光压平，使表面达到极高的平整度，满足半导体器件制造的严格要求。

" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理MicroFIT品牌全系列产品"> 艾美捷科技代理MicroFIT品牌全系列产品

...

阅读详情

艾美捷科技代理AkrivisBio品牌全系列产品

AkrivisBio是生命科学与生物技术领域的研究产品供应商，公司名"Akrivis"源自古希腊语，意为"精准"，彰显企业核心理念；"Bio"则界定我们其专业领域。AkrivisBio公司的核心产品线包括细胞增殖与毒性检测平台、代谢分析系统、样品分离与制备试剂盒、专业染色试剂盒以及生化试剂系列。

▎AkrivisBio产品线

●检测试剂盒（部分产品列表）

①细胞增殖与毒性检测：AkrivisBio公司提供多种细胞毒性及增殖检测方案，包括用于药物筛选的MTT法、MTS法和LDH检测法。我们的试剂盒操作简单、高效便捷，可兼容多种样本类型。

②代谢分析：AkrivisBio公司提供涵盖碳水化合物代谢、脂质代谢、氨基酸合成等多条通路的代谢检测试剂盒，用于精准定量代谢物、分析物及中间产物。试剂盒具有精度高、速度快、操作简便等优势，适用于各类样本，并兼容酶标仪、荧光酶标仪及分光光度计等常用检测设备。

③样品分离与制备试剂盒：产品线包含：细胞器分离富集试剂盒（线粒体、溶酶体等）、细胞组分分离试剂盒（细胞核、胞质蛋白、膜蛋白等）、以及TCA/PCA/SSA去蛋白试剂盒（用于分析前去除样本蛋白质）。这些试剂盒提供便捷高效的样本处理方案，分离后的样本可完美适配Western blot等下游应用。

④染色试剂盒：通过特异性染料或抗体标记目标分子，实现DNA、蛋白质、脂质、细胞器及特定标志物的可视化观测。AkrivisBio公司提供脂质染色试剂盒、细胞活性/毒性双染试剂盒、β-半乳糖苷酶染色试剂盒等系列产品，满足各类研究需求。

品名	货号	Size
LDH Based Cell Cytotoxicity Assay	CPT-0101	Includes reagents for 500 wells
Crystal Violet Cell Cytotoxicity Assay	CPT-0102	Includes reagents for 1000 wells
MTT Cell Proliferation Assay	CPT-0103	Includes reagents for 1000 wells
MTS Cell Proliferation Assay	CPT-0104	Includes reagents for 2500 wells
Quick Cell Proliferation Assay	CPT-0105	Includes reagents for 500 and 2500 wells
Ready-to-use Cell Proliferation Reagent	CPT-0106	Includes reagents for 2500 wells
Neutral Red Cell Cytotoxicity Assay	CPT-0107	Includes reagents for 1000 wells
Oil Red O Lipid Staining Kit	COS-0101	To stain two plates (6- 12-, 24- or 96-well) or five 100 mm culture dishes
Senescence Staining Assay	COS-0102	To stain 4X 24-, 12-, 6-well plates
Live vs. Dead Cell Differentiation Staining Kit	COS-0103	Includes reagent for staining 4 x 24-well plates.
Beta-galactosidase Staining Kit	COS-0104	Includes reagents to stain 20 x 12-well plates or the equivalent volume of 6 or 24-well plates.
Alkaline Phosphatase Staining Kit	COS-0105	Includes reagents to stain 96-, 48-, 24-, 12-, 6-well plates
Cell-Based Lysosomal Cytotoxicity Dual Staining Kit	COS-0106	50 assays
CaspACTIV Active Caspase-9 Staining Kit	COS-0107	25 wells, 100 wells
Annexin V-FITC Apoptosis Detection Kit	COS-0108	25 wells, 100 wells
Protein Myristoylation Assay	COS-0109	100 wells

●即用型微孔板

品名	货号	Size
Glucose RediPlate	RP-0122C	96 wells / 40 samples using background control or 80 samples without background controls
Pyruvate Kinase RediPlate	RP-0107C	96 wells / 40 samples using background control or 80 samples without background controls
Alkaline Phosphatase Activity Assay	RP-0109C	480 wells

●生化试剂（部分产品列表）

品名	货号	CAS号	分子式
2-Hexyl-4-Pentynoic Acid	B2834	96017-59-3	C₁₁H₁₈O₂
YW3-56 (hydrochloride)	B2858	-	C₂₇H₃₂ClN₅O₂.HCl
Destruxin A	B2947	6686-70-0	C₂₉H₄₇N₅O₇
Destruxin A	B2947 (Copy)	6686-70-0	C₂₉H₄₇N₅O₇
DTBA	B3242	1363376-98-0	C₄H₁₁NS₂·HCl
Telotristat	B338	1033805-28-5	C₂₅H₂₂ClF₃N₆O₃
AZD-4573	B3319	2057509-72-3	C₂₂H₂₈ClN₅O₂
Eltoprazine hydrochloride	B2301	98206-09-8	C₁₂H₁₆N₂O₂HCl
3-TYP	B2322	120241-79-4	C₇H₆N₄
LY-2510924	B2360	1088715-84-7	C₆₂H₈₇N₁₃O₁₁
Salermide	1873	1105698-15-4	C₂₆H₂₂N₂O₂
Atractyloside Potassium Salt	B2441	102130-43-8	C₃₀H₄₄K₂O₁₆S₂
PZ-2891	B2460	2170608-82-7	C₂₀H₂₃N₅O
Lanreotide Acetate	B2464	127984-74-1	C₅₄H₆₉N₁₁O₁₀S₂ · xC₂H₄O₂
Vesatolimod	B2555	1228585-88-3	C₂₂H₃₀N₆O₂
YW3-56 (hydrochloride)	B2858	-	C₂₇H₃₂ClN₅O₂.HCl
Sodium dichloroacetate	B3080	2156-56-1	C₂HCl₂NaO₂
Destruxin A	B2947	6686-70-0	C₂₉H₄₇N₅O₇
Pibrentasvir	B2168	1353900-92-1	C₅₇H₆₅F₅N₁₀O₈
STF-62247	B2210	315702-99-9	C₁₅H₁₃N₃S
Anastrozole	B2177	120511-73-1	C₁₇H₁₉N₅

" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理AkrivisBio品牌全系列产品"> 艾美捷科技代理AkrivisBio品牌全系列产品

...

阅读详情

艾美捷科技代理Synthelis Biotech品牌全系列产品

Synthelis Biotech是一家法国公司，专注于蛋白质的生产、纯化与表征，公司致力于助力疫苗、生物制剂、酶、工程蛋白、诊断工具以及高通量分子或配体筛选技术的开发。Synthelis Biotech提供经过验证的蛋白质，其活性和纯度均根据特定应用（候选药物筛选、抗体与疫苗开发、结构生物学、体外诊断、蛋白质载体化）量身定制。Synthelis Biotech专利的无细胞技术使客户能够从不同蛋白家族（GPCRs、离子通道、转运蛋白等）和不同形式（蛋白脂质体、纳米盘、去垢剂溶解形式或可溶形式）中选择合适的蛋白质。凭借其专利技术，Synthelis 能够在数小时内合成各类蛋白质：包括膜蛋白、毒性蛋白、修饰蛋白等，应用于药物筛选、疫苗与抗体开发、结构生物学以及体外诊断等领域。同时可按需进行修饰（荧光或同位素标记、非天然氨基酸掺入、截短或突变形式等）。

▍Synthelis Biotech产品列表

分类	品名	Protein	Origin	Format	Reference	Quantity	分子量
Viral Proteins	E1	Envelop protein 1	Hepatitis C virus	Proteoliposome	PL011	10µg, 20µg, 50µg, 100µg, 200µg, 500µg	21 kDa
Viral Proteins	E2	Envelop protein 1	Hepatitis C virus	Proteoliposome	PL010	10µg, 20µg, 50µg, 100µg, 200µg, 500µg	21 kDa
Viral Proteins	N-protein	Nucleocapsid Protein (COVID-19)	SARS-Cov 2 virus	Soluble	S-144	10µg, 20µg, 50µg, 100µg, 200µg, 500µg	47,7 kDa
Viral Proteins	F5L	Vaccinia virus major membrane protein	Vaccinia virus	Proteoliposome	PL007	10µg, 20µg, 50µg, 100µg, 200µg, 500µg	39.0 kDa
Viral Proteins	HCV p7	Hepatitis C virus P7	HCV virus	Proteoliposome	PL042	10µg, 20µg, 50µg, 100µg, 200µg, 500µg	7 kDa
GPCRs	APJ/AR	Apelin Receptor	Human	Proteoliposome	PL061	10 µg, 50 µg ,100 µg	44.7 kDa
GPCRs	B2R	Bradykinin receptor 2	Human	Proteoliposome	PL080	10 µg, 50 µg ,100 µg	47.0 kDa
GPCRs	BR	Bacteriorhodopsin	Bacteria	Proteoliposome	PL027	10 µg, 50 µg ,100 µg	29.4 kDa
GPCRs	CCR1	C-C chemokine receptor type 1	Human	Proteoliposome	PL021	10 µg, 50 µg ,100 µg	43.7 kDa
GPCRs	CCR2a	C-C chemokine receptor type 2, isoform a	Human	Proteoliposome	PL022	10 µg, 50 µg, 100 µg	44.5 kDa
GPCRs	CCR2b	C-C chemokine receptor type 2, isoform b	Human	Proteoliposome	PL023	10µg, 20µg,100 µg, 200 µg	42 kDa
GPCRs	CCR5	C-C chemokine receptor type 5	Human	Proteoliposome	PL024	10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk	40 kDa
GPCRs	CXCR4	C-X-C chemokine receptor type 4	Human	Proteoliposome	PL016	10 µg, 50 µg, 100 µg	43 kDa
GPCRs	CXCR4-Detergent	C-X-C chemokine receptor type 4	Human	Detergent	D016	25µg ,100 µg ,500 µg,bulk	40 kDa
GPCRs	GLP1R	Glucagon-like peptide 1 receptor	Human	Proteoliposome	PL067	10 µg, 50 µg, 100 µg	55.5 kDa
GPCRs	GPR50	G-protein coupled receptor 50	Human	Proteoliposome	PL095	10 µg, 50 µg, 100 µg	67.4 kDa
GPCRs	GPR54	G-protein coupled receptor 54	Human	Proteoliposome	PL097	10 µg, 50 µg ,100 µg	45.2 kDa
GPCRs	HMOP	Mu-type opioid receptor	Human	Proteoliposome	PL025	-	-
GPCRs	MT1	Melatonin receptor	Human	Proteoliposome	PL028	10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk	40 kDa
GPCRs	RXFP1	Relaxin receptor 1	Human	Proteoliposome	PL068	10 µg, 50 µg ,100 µg	89.1 kDa
Ion Channels	kir1.1b	ATP-sensitive inward rectifier potassium channel 1 isoform b	Mouse	Proteoliposome	PL031	10µg, 20µg,100 µg, 200 µg, 500 µg, bulk	42.7 kDa
Ion Channels	kv1.2	Potassium voltage-gated channel subfamily A, member 2	Rat	Proteoliposome	PL037	10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk	57 kDa
Ion Channels	kv1.3	Potassium voltage-gated channel subfamily A, member 3	Mouse	Proteoliposome	PL036	10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk	58 kDa
Ion Channels	VDAC1	Voltage-Dependent Anion Channel 1	Human	Proteoliposome	PL029	10 µg, 50 µg ,100 µg	30.7kDa
Ion Channels	VDAC1 – Detergent	Voltage-Dependent Anion Channel 1	Human	Detergent	D029	10 µg, 50 µg, 100 µg	30.7kDa
Ligands	SDF1a	Stromal cell-derived factor 1	Human	Soluble	S069	10 µg, 50 µg ,100 µg	10.7 kDa
Porins	OEP24	Outer envelope pore protein 24, chloroplastic	Plant	Proteoliposome	PL040	10 µg, 50 µg ,100 µg	24 kDa
Porins	OprF	Outer membrane porin F	Bacteria	Proteoliposome	PL045	10 µg, 50 µg, 100 µg	40 kDa
Enzymes	gp91phox (Nox2 subunit)	gp91phox	Human	Proteoliposome	PL008	10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk	55 kDa
Enzymes	KMO	Kynurenine 3-monooxygenase	Human	Proteoliposome	PL005	10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk	55,8 kDa
Enzymes	Nox2, p22 Phox	Cytochrome b-245 light chain	Human	Proteoliposome	PL039	10 µg, 50 µg ,100 µg	23,5 kDa
Enzymes	Nox4	Nox4	Human	Proteoliposome	PL059	10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk	67 kDa
Enzymes	PORCN	Protein-Cysteine N-palmitoyltransferase porcupine	Human	Proteoliposome	PL006	10 µg, 50 µg, 100 µg	55.5 kDa
Enzymes	TF	Tissue factor	Human	Proteoliposome	PL053	10µg, 20µg ,50µg, 100 µg , 200µg, 500 µg,bulk	33 kDa
Enzymes	T7 RNA Pol	T7 RNA Polymerase	Bacteriophage T7	Soluble	S192	10 µg, 50 µg, 100µg	100.1 kDa
Enzymes	DsbC	Disulfide bond isomerase	E.coli	Soluble	S197	customized quantity on request.	25.4 kDa
Receptors	CLDN 18.2	Claudin 18.2 Protein	Human	Proteoliposome	PL119	10 µg, 50 µg, 100 µg	30 kDa
Transcriptional regulators	AROS	Active regulator of SIRT1	Human	Proteoliposome	S052	10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk	15,4 kDa
Transporters	Bak	Bcl-2 homologous antagonist killer	Human	Proteoliposome	PL038	25µg ,100 µg ,500 µg,bulk	17 kDa
Transporters	EspH	Cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli	Bacteria	Proteoliposome	PL051	10 µg, 50 µg, 100 µg	21.9 kDa
Transporters	HCV p7	Hepatitis C virus P7	Virus	Proteoliposome	PL042	25µg ,100 µg ,500 µg,bulk	7 kDa
Transporters	NhaA	Na(+)/H(+) antiporter NhaA	E. coli	Proteoliposome	PL032	10 µg, 50 µg, 100 µg	43.9 kDa
Transporters	UCP1	Mitochondrial brown fat uncoupling protein 1	Mitochondria	Proteoliposome	PL047	10 µg, 50 µg, 100 µg	35.1 kDa

" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Synthelis Biotech品牌全系列产品"> 艾美捷科技代理Synthelis Biotech品牌全系列产品

...

阅读详情

艾美捷科技代理Innovotech品牌全系列产品

Innovotech公司专注于抗菌及生物膜解决方案领域。公司在标准化和定制化研究领域拥有卓越业绩，始终致力于满足客户需求。Innovotech的合同研究服务涵盖全周期：从早期问题识别与"抗生物膜活性"制剂筛选，到符合监管机构要求的产品宣称验证研究，再到用于营销推广的上市后产品比对研究。公司常规开发客户定制化体外模型作为研究起点，支持多维度测试参数的全面检测。

Innovotech的研发体系主要建立在两大专利技术平台：MBEC检测法®（最小生物膜根除浓度测定）和BEST检测法™（生物膜表观生存力检测）。基于这些平台，公司已开发出系列独特检测方法，适用于医疗、牙科、农业及工业领域中各类溶液态抗菌剂与表面涂层抗菌剂的测试。公司还融合平台技术与生物膜、医疗器械及银化学等领域的专业知识，开发出自有抗生物膜产品线：InnovoSIL™系列在医疗器械应用领域展现显著潜力，AgreGuard™-1在农业应用测试中验证卓越效力。Innovotech已构建测试平台的生物膜问题涉及导管及植入式医疗器械、抗生素药物研发、伤口愈合管理、特种涂料与防护涂层、水系统抗菌解决方案、牙科治疗及供水管线抗菌方案、农作物细菌/真菌病害防治、食品加工硬表面消毒剂等领域。

▍Innovotech产品列表

品名	产品描述	货号
MBEC Assay® Biofilm Inoculator with Trough Base & Cellulose Coated Pegs	The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. This MBEC Assay® Biofilm Inoculator consists of a plastic lid with 96 cellulose-coated pegs and a trough base. One of its recommended uses is with plant pathogens.	10/cs：19193；25/cs：19191；100/cs：19192
MBEC Assay® Biofilm Inoculator with 96 Well Base & Cellulose Coated Pegs	The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. This MBEC Assay® Biofilm Inoculator consists of a plastic lid with 96 cellulose-coated pegs and a well base. One of its recommended uses is with plant pathogens.	10/cs：19173；25/cs：19171；100/cs：19172
MBEC Assay® Biofilm Inoculator with Trough Base & Titanium Dioxide Coated Pegs	The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with a Titanium Dioxide coated well base.	10/cs：19163；25/cs：19161；100/cs：19162
MBEC Assay® Biofilm Inoculator with 96 Well Base & Titanium Dioxide Coated Pegs	The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with 96 Titanium Dioxide coated pegs and a well base.	10/cs：19153；25/cs：19151；100/cs：19152
MBEC Assay® Biofilm Inoculator with Trough Base & Hydroxyapatite Coated Pegs	The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with a Hydroxyapatite coated a well base.	10/cs：19143；25/cs：19141；100/cs：19142
MBEC Assay® Biofilm Inoculator with 96 Well Base & Hydroxyapatite Coated Pegs	The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with 96 Hydroxyapatite coated pegs and a well base.	10/cs：19133；25/cs：19131；100/cs：19132
MBEC Assay® Biofilm Inoculator with Trough Base	The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with a trough base.	10/cs：19123；25/cs：19121；100/cs：19122
MBEC Assay® Biofilm Inoculator with 96 Well Base	The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with 96 pegs well base.	10/cs：19113；25/cs：19111；100/cs：19112
InnovoSIL™-1 silver	The InnovoSIL™ family consists of novel antimicrobial silver complexes. InnovoSIL™-1 Antimicrobial Silver is ideally suited to coating onto or incorporating into medical devices, and is ready for testing.	-

" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Innovotech品牌全系列产品"> 艾美捷科技代理Innovotech品牌全系列产品

...

阅读详情

艾美捷科技代理Astra Biotech品牌全系列产品

Astra Biotech GmbH成立于2009年，专注于体外诊断（IVD）领域。Astra Biotech的产品目录包含用于检测激素紊乱、代谢疾病、肿瘤标志物以及过敏测试的试剂和体外诊断产品，其产品均基于可靠的ELISA技术或灵敏的PCR反应，所有ELISA试剂盒和PCR检测均通过CE认证，并经过严格的质量控制。

▍Astra Biotech产品线

● 抗体产品：高亲和力鼠源单克隆抗体（Mabs），靶向人源激素及蛋白靶点。

● 抗原原料：从培养上清液中分离，经凝胶层析、透析或亲和层析纯化的高纯度抗原。

● HRP 偶联物：抗体/抗原与辣根过氧化物酶（HRP）的活性偶联复合物。

● 校准品系统：含超高纯度抗原的血清基质校准品套装。

● 微孔板：预包被抗体或抗原的固相载体微孔板。

● ELISA 试剂盒：用于检测激素相关性疾病、感染性疾病、肿瘤标志物及过敏原的酶联免疫检测试剂盒。

● 分子遗传学产品：面向分子遗传性疾病诊断的PCR检测试剂盒。

● 重组蛋白产品：源于大肠杆菌或哺乳动物细胞系的重组蛋白/重组过敏原，适用于ELISA及Western Blot实验。

● 过敏原检测试剂：用于特异性IgE检测的生物素化过敏原。

● PCR 反应体系：即用型实时荧光定量PCR预混液、电泳试剂及多系列聚合酶。

▍Astra Biotech部分产品列表

品名	货号
DHEA-Sulfate ELISA kit	REF 20-01
Cortisol ELISA kit	REF 20-02
Anti-TPO ELISA kit	REF 24-06
Anti-TG ELISA kit	REF 24-07
TG ELISA kit	REF 24-08
CA-125 ELISA kit	REF 30-01
Gonadotropin hCG ELISA kit	REF 22-01
AFP ELISA kit	REF 22-02
Ferritin ELISA kit	REF 40-01
Ferritin ELISA kit	REF 40-01
Total IgE ELISA kit	REF 50-01
Chlamydia trachomatis PCR Kit	REF 84-11-56
Neisseria gonorrhoeae PCR kit	REF 84-03
Neisseria gonorrhoeae PCR kit	REF 84-04
Neisseria gonorrhoeae PCR kit	REF 84-01
Trichomonas vaginalis PCR kit	REF 84-05
Trichomonas vaginalis PCR kit	REF 84-06
Trichomonas vaginalis PCR kit	REF 84-02
Anti-AFP-mouse-mAb (IgG1)	10-01
Anti-AFP-mouse-mAb (IgG1)	10-02
Anti-Testosterone-mouse-mAb (IgG1)	10-03
Anti-Progesterone-mouse-mAb (IgG2b)	10-04
Anti-L-thyroxin-mouse-mAb (IgG2b)	10-05
Anti-hCG-mouse-mAb (IgG1)	10-06
Anti-hCG-mouse-mAb (IgG1)	10-07
Anti-Prolactin-mouse-mAb (IgG2a)	10-08
Anti-Prolactin-mouse-mAb (IgG1)	10-09
Anti-Cortisol mouse Mab (IgG2a)	10-10
Anti-CA-125-mouse-mAb (IgG1)	10-11
Anti-CA-125-mouse-mAb (IgG1)	10-12
Anti-Triiodothyronine-mouse-mAb (IgG1)	10-13
Cortisol-HRP Conjugate	12-01
Progesterone-HRP Conjugate	12-02
Testosterone-HRP Conjugate	12-03
DHEA-HRP Conjugate	12-04
T3-HRP Conjugate	12-05
T4-HRP Conjugate	12-06
Anti-IgE-HRP Conjugate	14-01
Anti-AFP-HRP Conjugate	14-04

" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Astra Biotech品牌全系列产品"> 艾美捷科技代理Astra Biotech品牌全系列产品

...

阅读详情

307 308 309 310 311 312 313 314 315 316

城市分站

友情链接 invivoCrown IV0100替换BioXCell BE0146 invivoCrown IV0112替换BioXCell BE0131 invivoCrown IV0111替换BioXCell BE0036 invivoCrown IV0104替换BioXCell BE0061 invivoCrown IV0115替换BioXCell BE0060 PhosphoSolutions Mimotopes Dendritics GORYO Chemical Bioporto

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：18771149750

传真：18771997407

邮箱：sales@amyjet.com

0.1609